Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review

被引：134

作者：

Fond, G. ^{[1
]}

Hamdani, N. ^{[1
]}

Kapczinski, F. ^{[2
,3
]}

Boukouaci, W. ^{[4
,5
]}

Drancourt, N. ^{[1
]}

Dargel, A. ^{[2
,3
,4
]}

Oliveira, J. ^{[4
,5
]}

Le Guen, E. ^{[1
]}

Marlinge, E. ^{[1
]}

Tamouza, R. ^{[4
,5
]}

Leboyer, M. ^{[1
]}

机构：

[1] Univ Paris Est Creteil, INSERM, U955, Fdn Fondamental Fdn Cooperat Sci Sante Mentale, Creteil, France

[2] Hosp Clin Porto Alegre, Ctr Pesquisas Expt, Lab Mol Psychiat, Porto Alegre, RS, Brazil

[3] INCT Translat Med, Porto Alegre, RS, Brazil

[4] Hop St Louis, Jean Dausset Lab, Paris, France

[5] Hop St Louis, INSERM, UMRS 940, Paris, France

来源：

ACTA PSYCHIATRICA SCANDINAVICA | 2014年 / 129卷 / 03期

关键词：

anti-inflammatory; cyclooxygenase-1; cyclooxygenase-2; non-steroidal anti-inflammatory drugs; celecoxib; salicylate; tumor necrosis factor; infliximab; minocycline; depression; schizophrenia; bipolar disorders; POLYUNSATURATED FATTY-ACIDS; SUPPLEMENTATION LOWERS INFLAMMATION; PLACEBO-CONTROLLED TRIALS; PROSTATE-CANCER RISK; DOUBLE-BLIND; BIPOLAR DISORDER; TNF-ALPHA; DEPRESSIVE DISORDER; ADJUNCTIVE THERAPY; EICOSAPENTAENOIC ACID;

D O I：

10.1111/acps.12211

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

ObjectiveTo provide a systematic review of the literature regarding the efficacy of anti-inflammatory drugs in three major mental disorders [major depressive disorder (MDD), schizophrenia and bipolar disorders]. MethodFour databases were explored, without any year or language restrictions. The baseline search paradigm was limited to open-labelled clinical and randomized controlled trials (RCTs). ResultsFour major classes of anti-inflammatory drugs were identified, namely polyunsaturated fatty acids (PUFAs), cyclooxygenase (COX) inhibitors, anti-TNFalpha and minocycline. Effectiveness and benefit/risk ratio of each class in MDD, bipolar disorders and schizophrenia was detailed when data were available. Several meta-analyses indicated effectiveness of PUFAs in MDD with a good tolerance profile. One meta-analysis indicated that COX-2 specific inhibitors showed effectiveness in schizophrenia. Anti-TNFalpha showed important effectiveness in resistant MDD with blood inflammatory abnormalities. Minocycline showed effectiveness in schizophrenia. ConclusionPolyunsaturated fatty acids seem to have the best benefit/risk ratio profile but proved their effectiveness only in MDD. A number of anti-inflammatory drugs are available as adjunct treatment for treatment-resistant patients with MDD, schizophrenia and bipolar disorder. If used with caution regarding their possible side-effects, they may be reasonable therapeutic alternatives for resistant symptomatology.

引用

页码：163 / 179

页数：17

共 178 条

[1] Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study [J].

Abbasi, Seyed-Hesameddin ;

Hosseini, Fahimeh ;

Modabbernia, Amirhossein ;

Ashrafi, Mandana ;

Akhondzadeh, Shahin .

JOURNAL OF AFFECTIVE DISORDERS, 2012, 141 (2-3) :308-314

[2] Cause for concern in the use of non-steroidal anti-inflammatory medications in the community -a population-based study [J].

Adams, Robert J. ;

Appleton, Sarah L. ;

Gill, Tiffany K. ;

Taylor, Anne W. ;

Wilson, David H. ;

Hill, Catherine L. .

BMC FAMILY PRACTICE, 2011, 12

[3] Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity [J].

Ahuja, Manuj ;

Bishnoi, Mahendra ;

Chopra, Kanwaljit .

TOXICOLOGY, 2008, 244 (2-3) :111-122

[4] Neuroinflammatory response to lipopolysaccharide is exacerbated in mice genetically deficient in cyclooxygenase-2 [J].

Aid, Saba ;

Langenbach, Robert ;

Bosetti, Francesca .

JOURNAL OF NEUROINFLAMMATION, 2008, 5 (1)

[5] Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial [J].

Akhondzadeh, Shahin ;

Tabatabaee, Maryam ;

Amini, Homayoun ;

Abhari, Seyed Ali Ahmadi ;

Abbasi, Seyed Hesamedin ;

Behnam, Behnaz .

SCHIZOPHRENIA RESEARCH, 2007, 90 (1-3) :179-185

[6] CLINICAL TRIAL OF ADJUNCTIVE CELECOXIB TREATMENT IN PATIENTS WITH MAJOR DEPRESSION: A DOUBLE BLIND AND PLACEBO CONTROLLED TRIAL [J].

Akhondzadeh, Shahin ;

Jafari, Sara ;

Raisi, Firoozeh ;

Nasehi, Abbas Ali ;

Ghoreishi, Aboulfazl ;

Salehi, Bahman ;

Mohebbi-Rasa, Soodeh ;

Raznahan, Maedeh ;

Kamalipour, Abbas .

DEPRESSION AND ANXIETY, 2009, 26 (07) :607-611

[7] Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood [J].

Appleton, Katherine M. ;

Rogers, Peter J. ;

Ness, Andrew R. .

AMERICAN JOURNAL OF CLINICAL NUTRITION, 2010, 91 (03) :757-770

[8] Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study [J].

Baddley, John W. ;

Winthrop, Kevin L. ;

Chen, Lang ;

Liu, Liyan ;

Grijalva, Carlos G. ;

Delzell, Elizabeth ;

Beukelman, Timothy ;

Patkar, Nivedita M. ;

Xie, Fenglong ;

Saag, Kenneth G. ;

Herrinton, Lisa J. ;

Solomon, Daniel H. ;

Lewis, James D. ;

Curtis, Jeffrey R. .

ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (11) :1942-1948

[9] Tolerance of biological agents in children [J].

Bader-Meunier, B. .

ARCHIVES DE PEDIATRIE, 2010, 17 (06) :962-963

[10] Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus [J].

Baik, EJ ;

Kim, EJ ;

Lee, SH ;

Moon, CH .

BRAIN RESEARCH, 1999, 843 (1-2) :118-129

← 1 2 3 4 5 6 7 8 9 10 →